The current study has been undertaken to develop new and biocompatible inhibitors for prolyl oligopeptidase, a highly specific endopeptidase, proposed to be involved, through its affinity for neuropeptides and kinins, in the processes of learning and memory and in the control of blood pressure. For in vitro evaluation of the inhibitors, human platelet prolyl oligopeptidase was purified to homogeneity and characterized. Northern blot analysis showed that mRNA coding for prolyl oligopeptidase was present in all tissues examined and only one transcript of 3.1 kb was detected. In addition to the human platelet enzyme, we also purified rat brain prolyl oligopeptidase, which proved to have the same characteristics as the human enzyme. In a series of tested peptides, bradykinin was found to be the best substrate. Based on this information, peptides bearing pseudopeptide bonds were generated and evaluated as inhibitors. The experiments clearly demonstrated that changes to the scissile peptide bond significantly decrease the affinity of prolyl oligopeptidase for the peptide derivatives. In our series of synthetic N-terminal blocked dipeptides, N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine was the most potent compound. Inhibition was reversible, but the inhibitor was bound tightly. Calculation of its K_i according to Henderson [Henderson, J. P. (1972) Biochem. J. 127, 321–333] yielded a value of 0.8 nM. This compound was not cytotoxic in a cell culture system and inhibited the purified prolyl oligopeptidase from rat as well as from human origin. In vivo evaluation in male Whistar rats showed no acute toxicity. 5 h after administration, the most profound decrease in prolyl oligopeptidase activity was found in the thymus, brain, and testis. This study demonstrates that N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine is a potent inhibitor and a promising compound suitable to investigate the physiologic function of the enzyme in vitro and In vivo.

Abbreviations

C1HgBzOH: p-chloromercuribenzoic acid
iPr₂P-F: diisopropyl fluorophosphate
Me₂SO: dimethyl sulphoxide
NHMec: 7-amino-4-metbylcoumarin
PhMeSO₂F: phenylmethylsulphonyl fluoride
Tic: l-1,2,3,4-tetrahydrolsoquinoline-3-carboxylic acid
Z-: N-benzyl-oxycarbonyl-
Z-Gly-Pro-NHMec: N-benzyloxycarbonyl-glycyl-prolyl-7-amino-4-methylcoumarin
Z-Pro-prolinal: N-benzyloxycarbonyl-prolyl-prolinal
Z-thiopro-thioprolinal: N-benzyloxycarbonyl-thioprolyl-thioprolinal
t-Boc: tertiary butyloxycarbonyl

Enzymes

: Prolyl oligopeptidase (EC 3.4.21.26)
: serine-type carboxy peptidase (EC 3.4.16.1)

References

Augustyns, K., Borloo, M., Belyaev, A., Rajan, P., Goossens, F., Hendriks, D., Scharpé, S. & Haemers, A. (1995) Synthesis of peptidyl acetals as inhibitors of prolyl endopeptidase, Bioorg. Med. Chem. Lett. 5, 1265–1270.
10.1016/0960-894X(95)00206-9
CASWeb of Science®Google Scholar
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248–254.
10.1016/0003-2697(76)90527-3
CASPubMedWeb of Science®Google Scholar
Bullock, T., Breddam, K. & Remington, S. J. (1996) Peptide aldehyde complexes with serine carboxypeptidase II: Implications for the catalytic mechanism and substrate specificity, J. Mol. Biol. 255, 714–725.
10.1006/jmbi.1996.0058
CASPubMedWeb of Science®Google Scholar
Clark, W. G. (1979) Bradykinin, kallidin and kallikrein, in Kinins and the peripheral and central nervous systems in bradykinin, kallidin and kallikrein ( E. G. Erdös, ed.) pp. 311–356, Springer-Verlag, Heidelberg .
Google Scholar
Cornish-Bowden, A. & Eisenthal, R. (1978) Estimation of the Michaelis constant and maximum velocity from the direct linear plot, Biochim. Biophys. Acta 573, 268–272.
Google Scholar
Dalmaz, C., Netto, C. A., Volkmer, N., Dias, R. D. & Izquerdo, I. (1986) Distribution of proline endopeptidase activity in sub-synaptosomal fractions of rat hypothalamus, Braz. J. Med. Biol. Res. 19, 685–690.
CASPubMedWeb of Science®Google Scholar
Dixon, M. (1972) The graphical determination of K_m and K_i, Biochem. J. 129, 197–202.
10.1042/bj1290197
CASPubMedWeb of Science®Google Scholar
Dresdner, K., Barker, L. A., Orlowski, M. & Wilk, S. (1982) Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain, J. Neurochem. 38, 1151–1158.
10.1111/j.1471-4159.1982.tb05362.x
CASPubMedWeb of Science®Google Scholar
Goossens, F., De Meester, I., Vanhoof, G. & Scharpé, S. (1992) A sensitive method for the assay of serum prolyl endopeptidase, Eur. J. Clin. Chem. Clin. Biochem. 30, 235–238.
CASPubMedWeb of Science®Google Scholar
Goossens, F., De Meester, I., Vanhoof, G., Hendriks, D., Vriend, G. & Scharpé, S. (1995) Prolyl oligopeptidase from human lymphocytes: purification, characterization and analysis of primary and secondary structure. Evidence that the enzyme belongs to the αlβ hydrolase fold family, Eur. J. Biochem. 233, 432–441.
10.1111/j.1432-1033.1995.432_2.x
CASPubMedWeb of Science®Google Scholar
Goossens, F., De Meester, I., Vanhoof, G. & Scharpé, S. (1996a) Distribution of prolyl oligopeptidase in human peripheral tissues and body fluid, Eur. J. Clin. Chem. Clin. Biochem. 34, 17–22.
CASPubMedWeb of Science®Google Scholar
Goossens, F., Wauters, J. G., Vanhoof, G. C., Bossuyt, P. J., Loens, K. & Scharpe, S. L. (1996b) Subregional mapping of the gene coding for human lymphocyte prolyl oligopeptidase to human chromosome 6q22. Cytogenet. Cell Genet. 74, 99–101.
10.1159/000134391
CASPubMedWeb of Science®Google Scholar
Henderson, J. P. (1972) A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors, Biochem. J. 127, 321–333.
10.1042/bj1270321
CASPubMedWeb of Science®Google Scholar
Kalwant, S. & Porter, G. (1991) Purification and characterization of human prolyl endopeptidase, Biochem. J. 276, 237–244.
10.1042/bj2760237
CASPubMedWeb of Science®Google Scholar
Kanatani, A., Yoshimoto, T., Kitazono, A., Kokubo, T. & Tsuru, D. (1993) Prolyl endopeptidase from Aemmonas hydrophila cloning, sequencing and expression of the enzyme gene and characterization of the expressed enzyme, J. Biochem. (Tokyo) 113, 790–796.
CASPubMedWeb of Science®Google Scholar
Kato, T., Okada, M. & Nagatsu, T. (1980) Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues, Mol. Cell. Biochem. 32, 117–121.
10.1007/BF00227437
CASPubMedWeb of Science®Google Scholar
Knisatschek, H. & Bauer, K. (1979) Characterization of ‘thyroliberindeamidating enzyme’ as a post-proline-cleaving enzyme, J. Biol. Chem. 254, 10936–10943.
CASPubMedWeb of Science®Google Scholar
Koida, M. & Walter, R. (1976) Post-proline cleaving enzyme - purification of the enzyme by affinity chromatography, J. Biol. Chem. 251, 7593–7599.
CASPubMedWeb of Science®Google Scholar
Li, J., Wilk, E. & Wilk, S. (1996) Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles, J. Neurochem. 66, 2105–2112.
10.1046/j.1471-4159.1996.66052105.x
CASPubMedWeb of Science®Google Scholar
Metzler, W. J., Bell, A. J., Ernst, E., Lavoie, T. B. & Mueller, L. (1994) Identification of the poly-l-proline-binding site on human profilin, J. Biol. Chem. 269, 4620–4625.
CASPubMedWeb of Science®Google Scholar
Michnick, S. W., Rosen, M. K., Wandless, T. J., Karplus, M. & Schreiber, S. L. (1991) Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin, Science 252, 836–842.
10.1126/science.1709301
CASPubMedWeb of Science®Google Scholar
Miura, N., Shibata, S. & Watanabe, S. (1995) Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats, Neurosci. Lett. 196, 128–130.
10.1016/0304-3940(95)11821-D
CASPubMedWeb of Science®Google Scholar
Moriyama, A., Nakanishi, M. & Sasaki, M. (1988) Porcine muscle prolyl endopeptidase and its endogenous substrates, J. Biochem. (Tokyo) 104, 112–117.
10.1093/oxfordjournals.jbchem.a122404
CASPubMedWeb of Science®Google Scholar
Nakajima, T., Ono, Y., Kato, A., Maeda, J. & Ohe, T. (1992) Y-29794 a non-peptide prolyl endopeptidase inhibitor that can penetrate into the brain, Neurosci. Lett. 141, 156–160.
10.1016/0304-3940(92)90884-A
CASPubMedWeb of Science®Google Scholar
O'Leary, R. & O'Connor, B. (1995) Identification and localization of a synaptosomal membrane prolyl oligopeptidase from bovine brain, Eur. J. Biochem. 227, 277–283.
10.1111/j.1432-1033.1995.tb20385.x
CASPubMedWeb of Science®Google Scholar
Orlowski, M., Wilk, E., Pearce, S. & Wilk, S. (1979) Purification and properties of a prolyl endopeptidase from rabbit brain, J. Neurochem. 33, 461–469.
10.1111/j.1471-4159.1979.tb05176.x
CASPubMedWeb of Science®Google Scholar
Ren, R., Mayer, B. J., Cichetti, P. & Baltimore, D. (1993) Identification of a ten-amino acid proline-rich SH3 binding site, Science 259, 1157–1161.
10.1126/science.8438166
CASPubMedWeb of Science®Google Scholar
Rennex, D., Hemmings, D., Hofsteenge, J. & Stone, S. (1991) cDNA cloning of the porcine prolyl endopeptidase and identification of its active site residues, Biochemistry 30, 2195–2203.
10.1021/bi00222a025
CASPubMedWeb of Science®Google Scholar
Scarso, A., Degelaen, J., Viville, R., De Cock, E., Van Marsenille, M., Van Der Auwera, L., Tourwé, D. & Van Binst, G. (1992) Synthesis and biological activities of bradykinin analogues with ψ (E,CH=CH) and ψ(CH₂-NH) isosteric peptide bond replacements, Bull. Soc. Chim. Belg. 100, 381–399.
Google Scholar
Schiavone, M., Santos, R., Brosnihan, B. & Khosla, M. (1988) Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin(1–7) heptapeptide, Proc. Natl Acad. Sci. USA 85, 4095–4098.
10.1073/pnas.85.11.4095
CASPubMedWeb of Science®Google Scholar
Shirasawa, Y., Osawa, T. & Hirashima, A. (1994) Molecular cloning and characterization of prolyl endopeptidase from human T cells, J. Biochem. (Tokyo) 115, 724–729.
10.1093/oxfordjournals.jbchem.a124402
CASPubMedWeb of Science®Google Scholar
Soeda, S., Ohyama, M., Yamakawa, N., Shimeno, H. & Nagamatsu, A. (1984) Two molecular species of proline endopeptidase in human plasma: isolation and characterization, Chem. Pharm. Bull. 32, 4061–4069.
10.1248/cpb.32.4061
CASPubMedWeb of Science®Google Scholar
Tapparelli, C., Metternich, R., Ehrhardt, C. & Cook, N. S. (1993) Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile, Trends Pharmacol. Sci. 14, 366–376.
10.1016/0165-6147(93)90095-2
CASPubMedWeb of Science®Google Scholar
Vanhoof, G., Goossens, F., Hendriks, L., De Meester, I., Hendriks, D., Vriend, G., Van Broeckhoven, C. & Scharpé, S. (1994) Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase, Gene (Amst.) 149, 363–366.
10.1016/0378-1119(94)90177-5
CASPubMedWeb of Science®Google Scholar
Walter, R., Shlank, H., Schwartz, I. L. & Kerenyi, T. D. (1971) Leucylglycinamide released from oxytocin by human uterine enzyme, Science 173, 827–829.
10.1126/science.173.3999.827
CASPubMedWeb of Science®Google Scholar
Weber, C., Wider, G., von Freyberg, B., Traber, R., Braun, W., Widmer, H. & Wüthrich, K. (1991) The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution, Biochemistry 30, 6563–6574.
10.1021/bi00240a029
CASPubMedWeb of Science®Google Scholar
Welches, W. R., Brosnihan, K. B. & Ferrario, C. M. (1993) A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11, Life Sci. 52, 1461–1480.
10.1016/0024-3205(93)90108-F
CASPubMedWeb of Science®Google Scholar
Wilk, S. & Orlowski, M. (1983) Inhibition of rabbit brain prolyl endopeptidase by N-benzyloxycarbonyl-prolyl-prolinal, transition state aldehyde inhibitor, J. Neurochem. 41, 69–75.
10.1111/j.1471-4159.1983.tb11815.x
CASPubMedWeb of Science®Google Scholar
Yoshimoto, T., Orlowski, R. & Walter, R. (1977) Post-proline cleaving enzyme: identification as a serine protease using active site specific inhibitors, Biochemistry 16, 2942–2948.
10.1021/bi00632a022
CASPubMedWeb of Science®Google Scholar
Yoshimoto, T., Ogita, K., Walter, R., Koida, M. & Tsuru, D. (1979) Post-proline cleaving enzyme – synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids in man, Biochim. Biophys. Acta 569, 184–192.
10.1016/0005-2744(79)90053-6
CASPubMedWeb of Science®Google Scholar
Yoshimoto, T., Walter, R. & Tsuru, D. (1980) Proline-specific endopeptidase from Flavobacterium, J. Biol. Chem. 255, 4786–4792.
10.1016/S0021-9258(19)85566-7
CASPubMedWeb of Science®Google Scholar
Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H. & Tsuru, D. (1987) Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect, J. Pharmacobio-Dyn. 10, 730–735.
10.1248/bpb1978.10.730
CASPubMedWeb of Science®Google Scholar
Yoshimoto, T., Tsuru, D., Yamamoto, N., Ikezawa, R. & Furukawa, S. (1991) Structure activity relationship of inhibitors specific for prolyl endopeptidase, Agric. Biol. Chem. 55, 37–43.
10.1271/bbb1961.55.37
CASPubMedWeb of Science®Google Scholar

Citing Literature

Volume250, Issue1

November (II) 1997

Pages 177-183

Journal list menu

Tools

Follow journal

Development and Evaluation of Peptide-Based Prolyl Oligopeptidase Inhibitors — Introduction of N-Benzyloxycarbonyl-Prolyl-3-Fluoropyrrolidine as a Lead in Inhibitor Design

Abstract

Abbreviations

Enzymes

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Journal list menu

Tools

Follow journal

Development and Evaluation of Peptide-Based Prolyl Oligopeptidase Inhibitors — Introduction of N-Benzyloxycarbonyl-Prolyl-3-Fluoropyrrolidine as a Lead in Inhibitor Design

Abstract

Abbreviations

Enzymes

References

Citing Literature

References

Related

Information